摘要
抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎是由抗NMDAR抗体介导的自身免疫性脑炎。目前研究发现抗NMDAR脑炎患者经免疫及肿瘤治疗后大多数预后良好, 但仍有4.5%~36.4%的患者复发。明确复发的危险因素对预防复发具有重要意义。本文拟对抗NMDAR脑炎复发的危险因素进行综述, 以期对预防复发提供帮助。
Anti-N-methyl-D-aspartate receptor(NMDAR)encephalitis is an autoimmune encephalitis mediated by anti-NMDAR antibody.Current studies have found that most patients with anti-NMDAR encephalitis have a good prognosis after immunotherapy and tumor therapy,but there are still 4.5%-36.4%patients with relapse.It is important to identify the risk factors for the prevention of relapse.This article aims to review the relapse risk factors of NMDAR encephalitis in order to provide help for the prevention of relapse.
作者
张方
李昱晨
申慧君
郭英石
王婧
王洁
Zhang Fang;Li Yuchen;Shen Huijun;Guo Yingshi;Wang Jing;Wang Jie(Graduate School,Shanxi Medical University,Taiyuan 030000,China;Department of Neurology,First Affiliated Hospital of Shanxi Medical University,Taiyuan 030001,China)
出处
《中华神经科杂志》
CAS
CSCD
北大核心
2023年第1期106-110,共5页
Chinese Journal of Neurology
作者简介
通信作者:王洁,Email:luwanglu2012@163.com。
